Boehringer Ingelheim

CLIMATE CHANGE AND HEALTH INEQUITY A DEADLY MIX FOR THE MOST VULNERABLE: WORLD HEART FEDERATION

Retrieved on: 
Wednesday, September 28, 2022

World leaders must step up efforts on the two biggest threats of our time: climate change and global health inequity."

Key Points: 
  • World leaders must step up efforts on the two biggest threats of our time: climate change and global health inequity."
  • Everyone is encouraged to get involved in World Heart Day and to learn more about better heart health.
  • This World Heart Day, they are proud to continue to support the World Heart Federation.
  • [2]In 2022, the World Heart Federation conducted a global pulse survey of 2500 people across 25 countries.

CLIMATE CHANGE AND HEALTH INEQUITY A DEADLY MIX FOR THE MOST VULNERABLE: WORLD HEART FEDERATION

Retrieved on: 
Wednesday, September 28, 2022

World leaders must step up efforts on the two biggest threats of our time: climate change and global health inequity."

Key Points: 
  • World leaders must step up efforts on the two biggest threats of our time: climate change and global health inequity."
  • Everyone is encouraged to get involved in World Heart Day and to learn more about better heart health.
  • This World Heart Day, they are proud to continue to support the World Heart Federation.
  • [2]In 2022, the World Heart Federation conducted a global pulse survey of 2500 people across 25 countries.

BOEHRINGER INGELHEIM DONATES NEARLY 100,000 PET VACCINE DOSES TO HELP ELIMINATE RABIES AROUND THE WORLD WITH RELAUNCH OF SHOTS FOR GOOD(SM) INITIATIVE

Retrieved on: 
Wednesday, September 28, 2022

DULUTH, Ga., Sept. 28, 2022 /PRNewswire/ -- Boehringer Ingelheim, a global leader in veterinary rabies vaccines, has expanded its commitment to help prevent rabies in dogs by donating nearly 100,000 doses of rabies vaccine. The donation is part of the relaunched SHOTS FOR GOOD℠ program and will be used on tribal lands and in underserved communities across the United States.

Key Points: 
  • Rabies is present on all continents, except Antarctica, with over 95% of human deaths occurring in the Asia and Africa regionsiii.
  • Dogs are the main source of human rabies deaths, contributing up to 99% of all rabies transmissions to humansiv.
  • "The generous vaccine donations from Boehringer Ingelheim Animal Health and the Shots for Good initiative helps to protect pets while making this important effort possible."
  • Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals.

PM360 Magazine Announces Winners of 2022 Trailblazer Awards

Retrieved on: 
Friday, September 23, 2022

NEW YORK, Sept. 23, 2022 /PRNewswire/ -- PM360, a leading life sciences marketing industry trade publication, announced the winners of their 14th annual Trailblazer Awards during an event held at Gotham Hall in New York City on Thursday, September 22, 2022. The awards recognize outstanding companies, CEOs, products, marketers, brand managers, and cutting-edge initiatives within the pharmaceutical, biotech, medical device, and diagnostics industries. In total, 72 winners were named across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives.

Key Points: 
  • NEW YORK, Sept. 23, 2022 /PRNewswire/ -- PM360, a leading life sciences marketing industry trade publication, announced the winners of their 14th annual Trailblazer Awards during an event held at Gotham Hall in New York City on Thursday, September 22, 2022.
  • The awards recognize outstanding companies, CEOs, products, marketers, brand managers, and cutting-edge initiatives within the pharmaceutical, biotech, medical device, and diagnostics industries.
  • Each of the winners were judged and selected by the PM360 Editorial Advisory Board, a cross section of experts from across the industry.
  • PM360 will publish profiles of this year's Trailblazer winners in its October issue and on its website.

ArisGlobal to Discuss Intelligent Automation, Data, and Analytics in Pharmacovigilance at World Drug Safety Congress Global Events

Retrieved on: 
Wednesday, September 21, 2022

MIAMI, Sept. 21, 2022 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces a series of technology and data-centric sessions at the 2022 World Drug Safety Congress (WDS) events, including a keynote by Chief Commercial Officer Aman Wasan at WDS Europe, followed by WDS Americas, featuring a keynote session by LifeSphere Safety product leader and acclaimed industry veteran, Beena Wood. 

Key Points: 
  • Kicking off the world tour is a series of conversations at WDS Europe, with three informative sessions over two days.
  • Attendees will hear Wasan, along with other innovative speakers, discuss the data and analytics opportunities in pharmacovigilance, including timely topics such as using intelligent analytics to unlock insights in data and how ArisGlobal's LifeSphere solutions are advancing pharmacovigilance today and driving future innovation.
  • Notably, ArisGlobal will lead a conversation with safety leaders from Boehringer Ingelheim, Moderna, and PMI on a panel discussing real-life results from pharmacovigilance automation.
  • ArisGlobal: ArisGlobal is led by passionate individuals who support life sciences leaders in developing and monitoring breakthrough medicines and therapies.

ArisGlobal to Discuss Intelligent Automation, Data, and Analytics in Pharmacovigilance at World Drug Safety Congress Global Events

Retrieved on: 
Wednesday, September 21, 2022

MIAMI, Sept. 21, 2022 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces a series of technology and data-centric sessions at the 2022 World Drug Safety Congress (WDS) events, including a keynote by Chief Commercial Officer Aman Wasan at WDS Europe, followed by WDS Americas, featuring a keynote session by LifeSphere Safety product leader and acclaimed industry veteran, Beena Wood. 

Key Points: 
  • Kicking off the world tour is a series of conversations at WDS Europe, with three informative sessions over two days.
  • Attendees will hear Wasan, along with other innovative speakers, discuss the data and analytics opportunities in pharmacovigilance, including timely topics such as using intelligent analytics to unlock insights in data and how ArisGlobal's LifeSphere solutions are advancing pharmacovigilance today and driving future innovation.
  • Notably, ArisGlobal will lead a conversation with safety leaders from Boehringer Ingelheim, Moderna, and PMI on a panel discussing real-life results from pharmacovigilance automation.
  • ArisGlobal: ArisGlobal is led by passionate individuals who support life sciences leaders in developing and monitoring breakthrough medicines and therapies.

Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)

Retrieved on: 
Wednesday, September 21, 2022

Preclinical data on BI 456906 will also be presented at the EASD annual meeting.

Key Points: 
  • Preclinical data on BI 456906 will also be presented at the EASD annual meeting.
  • BI 456906 is being developed by Boehringer Ingelheim and was co-invented with Zealand Pharma.
  • Most adverse events were reported during the dose-escalation phase of the trial, and therefore slower escalation schemes may mitigate the frequency.
  • Different doses of BI 456906 were escalated every 12 weeks to ensure that 10 weeks were spent on a maintenance dose.

Yankees Legend Bernie Williams and Celebrity Vocal Coach Eric Vetro Harness the Power of Music with Tune In To Lung Health® for Interstitial Lung Disease Awareness

Retrieved on: 
Wednesday, September 21, 2022

Together, they aim to address the many facets of ILD through educational resources that focus on the power of music and breath.

Key Points: 
  • Together, they aim to address the many facets of ILD through educational resources that focus on the power of music and breath.
  • Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9075951-boehringer-ingelheim-lau...
    "Tune In To Lung Health combines two things that are very close to my heartmusic and raising awareness of interstitial lung disease," said Williams.
  • "What I didn't know was how impactful music may be for some people living with interstitial lung disease.
  • To learn more about Tune In To Lung Health and access program resources, visit TuneInToLungHealth.com or follow along on social media:

Virtuosi® VR Education Platform becomes part of sterile manufacturing training at Boehringer Ingelheim

Retrieved on: 
Tuesday, September 20, 2022

ATLANTA, Ga., Sep. 20, 2022 /PRNewswire-PRWeb/ -- Quality Executive Partners Inc (QxP) is pleased to announce the deployment of Virtuosi® at Boehringer Ingelheim. Boehringer Ingelheim has deployed Virtuosi, the tech-forward one-of-a-kind educational platform, at three aseptic sites across its network. Virtuosi focuses the learning experience on the "why" level. It leverages the power of virtual reality (VR) immersive experiences to foster the long-term memory of the learner.

Key Points: 
  • ATLANTA, Ga., Sep. 20, 2022 /PRNewswire-PRWeb/ -- Quality Executive Partners Inc (QxP) is pleased to announce the deployment of Virtuosi at Boehringer Ingelheim.
  • Boehringer Ingelheim has deployed Virtuosi , the tech-forward one-of-a-kind educational platform, at three aseptic sites across its network.
  • Virtuosi is helping Boehringer Ingelheim to further advance the skills and knowledge necessary in sterile manufacturing using tech-forward innovation," said Crystal Mersh, CEO of QxP.
  • Virtuosi powered by QxP is the world's first and only comprehensive multi-language immersive training platform for pharmaceutical manufacturing operators in aseptic processing, microbiology, and cell and gene therapy processing.

Virtuosi® VR Education Platform becomes part of sterile manufacturing training at Boehringer Ingelheim

Retrieved on: 
Tuesday, September 20, 2022

ATLANTA, Sept. 20, 2022 /PRNewswire/ -- Quality Executive Partners Inc (QxP) is pleased to announce the deployment of Virtuosi at Boehringer Ingelheim.

Key Points: 
  • ATLANTA, Sept. 20, 2022 /PRNewswire/ -- Quality Executive Partners Inc (QxP) is pleased to announce the deployment of Virtuosi at Boehringer Ingelheim.
  • Boehringer Ingelheim has deployed Virtuosi, the tech-forward one-of-a-kind educational platform, at three aseptic sites across its network.
  • It leverages the power of virtual reality (VR) immersive experiences to foster the long-term memory of the learner.
  • Virtuosi is helping Boehringer Ingelheim to further advance the skills and knowledge necessary in sterile manufacturing using tech-forward innovation," said Crystal Mersh, CEO of QxP.